Literature DB >> 33130336

Labeling and tracking cells with gold nanoparticles.

Ramya Chandrasekaran1, Thiagarajan Madheswaran2, Nagendran Tharmalingam3, Rajendran Jc Bose4, Hansoo Park5, Don-Hyung Ha6.   

Abstract

Gold nanoparticles (AuNPs) have garnered much attention as contrast agents for computerized tomography (CT) because of their facile synthesis and surface functionalization, in addition to their significant X-ray attenuation and minimal cytotoxicity. Cell labeling using AuNPs and tracking of the labeled cells using CT has become a time-efficient and cost-effective method. Actively targeted AuNPs can enhance CT contrast and sensitivity, and further reduce the radiation dosage needed during CT imaging. In this review, we summarize the state-of-the-art use of AuNPs in CT for cell tracking, including the precautionary steps necessary for their use and the difficulty in translating the process into clinical use.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33130336     DOI: 10.1016/j.drudis.2020.10.020

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

1.  Analysis of cell-nanoparticle interactions and imaging of in vitro labeled cells showing barcorded endosomes using fluorescent thiol-organosilica nanoparticles surface-functionalized with polyethyleneimine.

Authors:  Michihiro Nakamura; Junna Nakamura; Chihiro Mochizuki; Chika Kuroda; Shigeki Kato; Tomohiro Haruta; Mayu Kakefuda; Shun Sato; Fuyuhiko Tamanoi; Norihiro Sugino
Journal:  Nanoscale Adv       Date:  2022-05-06

2.  Characterization of Intrinsically Radiolabeled Poly(lactic-co-glycolic acid) Nanoparticles for ex Vivo Autologous Cell Labeling and in Vivo Tracking.

Authors:  Massis Krekorian; Gerwin G W Sandker; Kimberley R G Cortenbach; Oya Tagit; N Koen van Riessen; René Raavé; Mangala Srinivas; Carl G Figdor; Sandra Heskamp; Erik H J G Aarntzen
Journal:  Bioconjug Chem       Date:  2021-06-23       Impact factor: 4.774

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.